Director
New Mexico Clinical Research & Osteoporosis Center
E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 350 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis.
Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial board of the Journal of Clinical Densitometry.
He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.
Tuesday, March 28, 2023
8:00 AM – 5:00 PM
Disclosure(s): Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Contracted Research (PI’s must provide disclosure in this category) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing); Radius: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)
Thursday, March 30, 2023
10:45 AM – 11:45 AM
Disclosure(s): Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Contracted Research (PI’s must provide disclosure in this category) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing); Radius: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)
Thursday, March 30, 2023
11:45 AM – 12:45 PM
Disclosure(s): Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Contracted Research (PI’s must provide disclosure in this category) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing); Radius: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)